HitGen Unveils Its 2025 Sustainability Report Highlighting ESG Initiatives

On April 29, 2026, HitGen Inc., a company listed on the Shanghai Stock Exchange (SSE: 688222.SH), publicly released its second Sustainability Report for the year 2025. The report is designed to convey HitGen's corporate philosophies and policies related to environmental, social, and governance (ESG) practices, as well as its performance in sustainable development over that year. This comprehensive document aims to address the concerns of stakeholders by presenting a systematic evaluation of HitGen's initiatives and achievements.

Commitment to Value Creation

Dr. Jin Li, Chairman and CEO of HitGen Inc., emphasized the company's commitment to improving human health, stating, "The core of our company lies in continuously creating value." Reflecting on 2025, Dr. Jin highlighted the integration of sustainable development into the company's overall strategy, management, and operations. This alignment is seen as essential for fostering long-term success and yielding positive contributions to various partners, including customers, investors, and communities.

Strengthening Corporate Governance

HitGen is dedicated to enhancing its corporate governance framework by adhering to principles of integrity and business ethics. The report outlines how the company is setting industry benchmarks through the establishment of a robust risk management system. This initiative is aimed at ensuring the company's stability and profitability, ultimately generating sustainable value for all stakeholders involved.

Fostering a Responsible Value Chain

The report also underscores HitGen's commitment to maintaining product safety and service quality while developing a sustainable supply chain. The company systematically manages all value chain aspects and seeks to create long-lasting value by collaborating with its stakeholders. These practices reflect HitGen's dedication to responsible and ethical business operations.

Valuing Employees and Community Engagement

HitGen identifies its employees as the pivotal force driving the company forward and recognizes local communities as essential partners in its sustainable development journey. The firm is committed to a people-centric philosophy and is focused on societal contributions. The initiatives outlined in the report include promoting employee well-being and fostering co-development with communities to create a mutually beneficial environment.

Embracing Environmental Responsibility

A significant aspect of HitGen's sustainability approach is its commitment to green development. This concept permeates the company’s operational and developmental strategies. The report details actions taken towards improving environmental management, ecological protection, and resource utilization while also addressing climate change. Dr. Jin stated, "Every step counts, leading to great distances," indicating that the company’s progressive actions will significantly contribute to environmental conservation and sustainability.

A Vision for the Future

As HitGen embarks on its journey to become a world-class innovative biopharmaceutical enterprise, it remains focused on market demands and technological advancements. By continuously enhancing its innovative drug discovery services, HitGen aims to help construct a healthier, greener, and more inclusive world. The 2025 Sustainability Report serves as a testament to these goals, showcasing HitGen's steadfast commitment to making the world a better place through its operations.

For additional details, you can explore HitGen's Sustainability Report at HitGen's Official Website.

About HitGen Inc.

HitGen Inc. is committed to becoming a leading biopharmaceutical enterprise dedicated to improving human health and quality of life through the development of innovative therapeutic solutions. Utilizing its advanced DEL (DNA-encoded Library) technology, the company has ventured into various areas such as Fragment-Based Drug Discovery and Structure-Based Drug Design. Headquartered in Chengdu, China, HitGen operates globally with subsidiaries in the UK and USA and has collaborated with over 600 clients worldwide to facilitate numerous drug development projects. For more information, visit HitGen's Website.